Laura Adkins
Researcher
Also affiliated: University of Alaska Anchorage (2026); Central Arkansas Veterans Healthcare System (2004); Winthrop Rockefeller Foundation (2008–2016); Alaska Neurology Center (2026)
Faculty Researcher
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Laura Adkins' research focuses on breast cancer treatment and surgical outcomes. She is the principal investigator on the Ablation after Breast Lumpectomy Added To Extend (ABLATE) trial, a prospective, multicenter phase II study investigating intraoperative margin ablation as a sole local treatment for breast cancer. Adkins has published on sentinel lymph node biopsy and its role in breast cancer management. Her work involves collaborations with other researchers at the University of Arkansas for Medical Sciences, including Daniela Ochoa, Ronda Henry‐Tillman, and V Suzanne Klimberg.
Adkins' scholarship metrics include an h-index of 12, with 15 total publications and 942 citations. She is noted as recently active in her research endeavors.
Metrics
- h-index: 12
- Publications: 15
- Citations: 944
Selected Publications
-
ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer (2026)
-
Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer (2026)
-
Does Axillary Reverse Mapping Prevent Lymphedema After Lymphadenectomy? (2016)
-
Long-Term Results of Phase II Ablation after Breast Lumpectomy Added to Extend Intraoperative Margins (ABLATE l) Trial (2014)
-
Axillary reverse mapping: Five-year experience (2014)
-
Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy. (2012)
-
Long-Term Results of Excision Followed by Radiofrequency Ablation as the Sole Means of Local Therapy for Breast Cancer (2012)
-
Feasibility of Percutaneous Excision Followed by Ablation for Local Control in Breast Cancer (2011)
-
Intraoperative Injection of Subareolar or Dermal Radioisotope Results in Predictable Identification of Sentinel Lymph Nodes in Breast Cancer (2011)
-
Scientific Impact Award: Axillary reverse mapping (ARM) to identify and protect lymphatics draining the arm during axillary lymphadenectomy (2009)
-
Intraoperative Radioisotope Injection for Sentinel Lymph Node Biopsy (2008)
-
Axillary Reverse Mapping: Mapping and Preserving Arm Lymphatics May Be Important in Preventing Lymphedema During Sentinel Lymph Node Biopsy (2008)
-
Axillary Reverse Mapping (ARM): A New Concept to Identify and Enhance Lymphatic Preservation (2007)
-
eRFA: Excision Followed by RFA—a New Technique to Improve Local Control in Breast Cancer (2006)
-
Intraoperative Subareolar Radioisotope Injection for Immediate Sentinel Lymph Node Biopsy (2004)
Collaboration Network
Top Collaborators
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
- Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer
Similar Researchers
Based on overlapping research topics